Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness

European Archives of Oto-Rhino-Laryngology

Volumn 271, Issue 1, 2014, Pages 171-179

  Hou, Weijian ^a   He, Weiling ^a   Li, Yuhuang ^b   Ma, Renqiang ^a   Wang, Zhangfeng ^a   Zhu, Xiaolin ^a   Fu, Qingling ^a   Wen, Yihui ^a   Li, Huabin ^a   Wen, Weiping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aldehyde dehydrogenase 1A1; Growth; Nasopharyngeal carcinoma; Proliferation; Tumorigenesis

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1 A1; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

ALDEHYDE DEHYDROGENASE; ANIMALS; CARCINOGENICITY TESTS; CELL PROLIFERATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 84892932680     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-013-2517-x     Document Type: Article

References (22)

1. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365:2041-2054
2. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM (2008) Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 30:946-963
3. Tao Q, Chan AT (2007) Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9:1-24
4. Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17:313-319
5. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Göktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G, Rupec RA, Gerhard M, Schmid R, Barker N, Clevers H, Lang R, Neumann J, Kirchner T, Taketo MM, van den Brink GR, Sansom OJ, Arkan MC, Greten FR (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152:25-38
6. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:3382-3389
7. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7(3):330-338
8. Douville J, Beaulieu R, Balicki D (2009) ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 18:17-25
9. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567
10. Madjd Z, Ramezani B, Molanae S, Asadi-Lari M (2012) High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. Asian Pac J Cancer Prev 13:2973-2978
11. Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, Windhager R, Leithner A (2012) Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma. PLoS One 7:e43664
12. Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, Zori R, Gray BA, Moreb JS (2009) Aldehyde dehydrogenase activity as functional marker for lung cancer. Chem Biol Interact 178:48-55
13. Wu A, Luo W, Zhang Q, Yang Z, Zhang G, Li S, Yao K (2013) Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma. Cancer Lett 330:181-189
14. Huang XM, Dai CB, Mou ZL, Wang LJ, Wen WP, Lin SG, Xu G, Li HB (2009) Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy. Cancer Lett 279:47-56
15. Fang J, Lei W, Huang X, Li P, Chen X, Zhu X, Wen W, Li H (2012) Expression of mismatch repair gene PMS2 in nasopharyngeal carcinoma and regulation by glycogen synthase kinase-3b in vivo and in vitro. Auris Nasus Larynx 39:71-76
16. Cabarcas SM, Mathews LA, Farrar WL (2011) The cancer stem cell niche-there goes the neighborhood? Int J Cancer 129:2315-2327
17. Dirks P (2010) Cancer stem cells: invitation to a second round. Nature 466:40-41
18. Nicolini A, Ferrari P, Fini M, Borsari V, Fallahi P, Antonelli A, Carpi A, Miccoli P (2011) Cancer stem cells: perspectives of new therapeutical approaches for breast cancer. Front Biosci 3:1486-1499
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
20. Balicki D (2007) Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. Cell Stem Cell 15:485-487
21. Meregalli M, Farini A, Belicchi M, Torrente Y (2010) CD133(?) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther 10:1521-1528
22. Pearce DJ, Ridler CM, Simpson C, Bonnet D (2004) Multiparameter analysis of murine bone marrow side population cells. Blood 103:2541-2546